Background: Artificial pancreas (AP) systems are currently an active field of diabetes research. This pilot study examined the attitudes of AP clinical trial participants toward future acceptance of the technology, having gained firsthand experience. Subjects and Methods: After possible influencers of AP technology adoption were considered, a 34-question questionnaire was developed. The survey assessed current treatment satisfaction, dimensions of clinical trial participant motivation, and variables of the technology acceptance model (TAM). Forty-seven subjects were contacted to complete the survey. The reliability of the survey scales was tested using Cronbach's a. The relationship of the factors to the likelihood of AP technology adoption was explored using regression analysis. Results: Thirty-six subjects (76.6%) completed the survey. Of the respondents, 86.1% were either highly likely or likely to adopt the technology once available. Reliability analysis of the survey dimensions revealed good internal consistency, with scores of >0.7 for current treatment satisfaction, convenience (motivation), personal health benefit (motivation), perceived ease of use (TAM), and perceived usefulness (TAM). Linear modeling showed that future acceptance of the AP was significantly associated with TAM and the motivation variables of convenience plus the individual item benefit to others (R 2 = 0.26, P = 0.05). When insulin pump and continuous glucose monitor use were added, the model significance improved (R 2 = 0.37, P = 0.02). Conclusions: This pilot study demonstrated that individuals with direct AP technology experience expressed high likelihood of future acceptance. Results support the factors of personal benefit, convenience, perceived usefulness, and perceived ease of use as reliable scales that suggest system adoption in this highly motivated patient population.
“Innovation” has become a ubiquitous term in the business of health care. The concept of disruptive innovation adds a new complexity to this popular notion. The emergence of artificial intelligence, virtual reality, and venture capitalists generates excitement, doubt, and curiosity for stakeholders across health care organizations. As companies such as Amazon, Apple, CVS, and JP Morgan enter this sector, disruptions will emerge that aim to improve the quality of care while reducing overall cost. The purpose of this article is to differentiate the concepts of innovation and disruptive innovation, explore their significance to the nursing profession, and outline 3 key roles nurse leaders can occupy as they navigate the future ever-changing trajectory of health care.
This study developed the construct of readiness for renewal in organizations and evaluated its underlying psychometric properties. We drew on Discourse of Renewal theory to develop, pilot, and refine a scale through three studies with full-time employees whose organizations recently experienced crises. Study 1 established a two-factor structure that included ethical communication and effective organizational rhetoric. Using confirmatory factor analysis in Study 2, we replicated the two-factor solution. Because of a high correlation between factors, we modified the model to include a higher order factor predicting the two lower order factors. Study 3 translated the questionnaire and replicated findings from Study 2 with full-time employees in Mexico. The resulting 15-item instrument in English and Spanish can be used by researchers and practitioners interested in assessing precrisis readiness through the Discourse of Renewal.
Extant communication research on negotiation typically focuses on the microprocesses of interaction without much attention to the larger context in which these conflicts occur. However, public campaigns related to labor‐management conflicts impinge on the way negotiations are enacted. This study focuses on the turning points and conflict framing in the 2007–2008 conflict between the Writers Guild of America and the Alliance of Motion Picture and Television Producers. Using media coverage and press releases, it examines turning points across critical events, communicative framing, and the role of a simultaneous corporate campaign in shaping the outcome of this negotiation. Overall, it demonstrates that procedural precipitants in combination with the corporate campaign triggered departures that escalated the conflict, while procedural and external precipitants shaped departures that led to an agreement. Writers Guild of America's particular brand of a soft corporate campaign played an important role in solidifying the labor union and garnering public support for the strike.
Nonprofit organizations have somewhat different foci, contexts, and resources than typical for‐profit organizations, so may have experienced and responded to COVID‐19 in ways not covered in traditional corporate research. We investigate the influence of nonprofit organizations' communication support and use, crisis experience and preparation, and extent and impacts of COVID‐19 on their strategic responses to the crisis (from retrenchment to perseverance to innovation). Our study is a longitudinal panel survey conducted with 578 U.S. public charities, once before the pandemic and the other 6 months into it. Data were analyzed using descriptive statistics to characterize the sample, and hierarchical regressions to assess the influences on strategic responses to the COVID‐19 pandemic. A major finding is that communication with external stakeholders predicted organizations' abilities to maintain core activities (perseverance) during a crisis and to pivot (innovating) on mission delivery. Practical applications for nonprofit organizations are addressed, with particular attention to COVID‐19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.